London, May 19, 2026, 15:03 (BST)
- Tate & Lyle traded at 514.5 GBX, or pence, at 15:00 BST, down 1.25% on the day and well below Ingredion’s possible 615p-per-share value. Google
- The stock is moving inside an active UK takeover process after Ingredion made a non-binding 595p cash proposal, with up to 20p more in permitted dividends. Investegate
- Investors also face Tate & Lyle’s full-year results on May 21, two days before the next immediate test of the company’s standalone story. Tate & Lyle
Tate & Lyle shares fell in London trade on Tuesday, widening the gap between the stock price and U.S. rival Ingredion’s possible offer as investors waited for evidence that the bid will harden into a binding deal. The shares were at 514.5 GBX at 15:00 BST, down 1.25%, after opening at 521p and touching a day’s low of 513p. Google
That discount matters now. Ingredion has proposed value of up to 615p a share, made up of 595p in cash and up to 20p in dividends, but both companies have said there is no certainty a firm offer will be made. Investegate
Tate & Lyle, the London-listed food ingredients group, said last week its board was in discussions with Ingredion after a number of earlier approaches. Under UK takeover rules, Ingredion has until 5:00 p.m. London time on June 11 to announce a firm offer or say it will not bid, unless the deadline is extended. Tate & Lyle
The stock’s move also came against a firmer UK mid-cap tape. Reuters reported that the FTSE 250 rose 0.81% by 11:13 GMT after softer labour-market data eased concerns about an immediate Bank of England rate hike. Reuters
The price action suggests traders are still assigning risk to the bid. Tate & Lyle’s shares are below both the 595p cash element and the possible 615p total value, even after a sharp rally when the proposal first became public. Reuters reported on May 14 that the stock had surged as much as 55% after the talks were disclosed. Reuters
“This is a level that the board would have to consider,” Lucinda Guthrie, head of Mergermarket, told Reuters last week, adding that disclosure of the approach would act as a “price discovery mechanism” for whether a deal can be struck. Reuters
Ingredion said the possible transaction would deliver “significant benefits” to customers, consumers, employees and its shareholders. The U.S. company said it was in discussions and due diligence, meaning a review of Tate & Lyle’s business before any binding offer, but reserved the right to vary the offer structure. Investegate
A deal would combine two sweeteners and starches businesses at a time when food companies are reformulating products to cut sugar and calories. Reuters said Tate & Lyle supplies ingredients used by food groups including Unilever and Nestle, and that a merger with Ingredion could create a food and beverage ingredients group worth more than $10 billion. Reuters
There was a second, smaller thread for investors on Monday: Tate & Lyle expanded its collaboration with BioHarvest Sciences to develop multiple plant-based sweetener molecules, broadening a programme that began in 2024. Victoria Spadaro-Grant, Tate & Lyle’s chief science and innovation officer, said the expansion reflected technical progress and that multiple unmet market needs were unlikely to be solved by one sweetener. Investing
Still, the takeover clock is likely to dominate. Regulatory notices on Tuesday showed a stream of Form 8.3 and Form 8.5 disclosures, filings required during UK takeover situations from investors and market participants with relevant positions or dealings. London South East
The near-term risk is simple: Ingredion could walk away, lower the economic value in some agreed structure, or face pushback on price, timing or approvals. Tate & Lyle’s own results are due on May 21, when investors will get a fresher look at demand, costs and the CP Kelco integration before deciding how much value sits in the company without a bid. Tate & Lyle
